These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 1932479)
1. Inhibition of gastrin- and histamine-stimulated gastric acid secretion by gastrin and cholecystokinin antagonists in the rat. Hirst BH; Elliott KJ; Ryder H; Szelke M Aliment Pharmacol Ther; 1991 Feb; 5(1):31-9. PubMed ID: 1932479 [TBL] [Abstract][Full Text] [Related]
2. The effect of CCKB/gastrin antagonists on stimulated gastric acid secretion in the anaesthetized rat. Hayward NJ; Harding M; Lloyd SA; McKnight AT; Hughes J; Woodruff GN Br J Pharmacol; 1991 Dec; 104(4):973-7. PubMed ID: 1687371 [TBL] [Abstract][Full Text] [Related]
3. YF476 is a new potent and selective gastrin/cholecystokinin-B receptor antagonist in vitro and in vivo. Takinami Y; Yuki H; Nishida A; Akuzawa S; Uchida A; Takemoto Y; Ohta M; Satoh M; Semple G; Miyata K Aliment Pharmacol Ther; 1997 Feb; 11(1):113-20. PubMed ID: 9042983 [TBL] [Abstract][Full Text] [Related]
4. L-365,260, a potent CCK-B/gastrin receptor antagonist, suppresses gastric acid secretion induced by histamine and bethanechol as well as pentagastrin in rats. Nishida A; Yuki H; Tsutsumi R; Miyata K; Kamato T; Ito H; Yamano M; Honda K Jpn J Pharmacol; 1992 Feb; 58(2):137-45. PubMed ID: 1354760 [TBL] [Abstract][Full Text] [Related]
5. Different effects of CCK antagonists on gastric-acid response to CCK and pentagastrin. Corwin RL; Smith GP Peptides; 1993; 14(2):253-7. PubMed ID: 8483804 [TBL] [Abstract][Full Text] [Related]
6. YM022, a highly potent and selective CCKB antagonist inhibiting gastric acid secretion in the rat, the cat and isolated rabbit glands. Attoub S; Moizo L; Laigneau JP; Alchepo B; Lewin MJ; Bado A Fundam Clin Pharmacol; 1998; 12(3):256-62. PubMed ID: 9646057 [TBL] [Abstract][Full Text] [Related]
8. CCK1 and CCK2 receptors regulate gastric pepsinogen secretion. Blandizzi C; Lazzeri G; Colucci R; Carignani D; Tognetti M; Baschiera F; Del Tacca M Eur J Pharmacol; 1999 May; 373(1):71-84. PubMed ID: 10408253 [TBL] [Abstract][Full Text] [Related]
9. Role of gastrin and cholecystokinin receptors in regulation of peptone-stimulated gastric acid secretion in conscious rats. Varga G; Campbell DR; Bussjaeger LJ; Solomon TE Eur J Pharmacol; 1993 Nov; 250(1):37-42. PubMed ID: 8119323 [TBL] [Abstract][Full Text] [Related]
10. Cholecystokinin type B receptor antagonist PD-136,450 is a partial secretory agonist in the stomach and a full agonist in the pancreas of the rat. Schmassmann A; Garner A; Flogerzi B; Hasan MY; Sanner M; Varga L; Halter F Gut; 1994 Feb; 35(2):270-4. PubMed ID: 8307482 [TBL] [Abstract][Full Text] [Related]
11. Effects of YF476, a potent and selective gastrin/cholecystokinin-B receptor antagonist, on gastric acid secretion in beagle dogs with gastric fistula. Takemoto Y; Yuki H; Nishida A; Ito H; Kobayashi-Uchida A; Takinami Y; Akuzawa S; Ohta M; Satoh M; Semple G; Miyata K Arzneimittelforschung; 1998 Apr; 48(4):403-7. PubMed ID: 9608884 [TBL] [Abstract][Full Text] [Related]
12. Effect of cholecystokinin receptor antagonists, MK-329 and L-365,260, on cholecystokinin-induced acid secretion and histidine decarboxylase activity in the rat. Kawabata S; Kanayama S; Shinomura Y; Miyazaki Y; Imamura I; Moriwaki K; Wada H; Tarui S Regul Pept; 1991 Jul; 35(1):1-10. PubMed ID: 1924892 [TBL] [Abstract][Full Text] [Related]
13. YM022, a potent and selective gastrin/CCK-B receptor antagonist, inhibits peptone meal-induced gastric acid secretion in Heidenhain pouch dogs. Yuki H; Nishida A; Miyake A; Ito H; Akuzawa S; Takinami Y; Takemoto Y; Miyata K Dig Dis Sci; 1997 Apr; 42(4):707-14. PubMed ID: 9125636 [TBL] [Abstract][Full Text] [Related]
14. Role of cholecystokinin in the intestinal fat- and acid-induced inhibition of gastric secretion. Konturek SJ; Bilski J; Cieszkowski M Regul Pept; 1992 Nov; 42(1-2):97-109. PubMed ID: 1475410 [TBL] [Abstract][Full Text] [Related]
15. Attenuation of gastrin-induced gastric acid secretion by antisense oligonucleotide to the CCKB/gastrin receptor. Rao RK; Lopez Y; Lai J; Riviere PJ; Junien JL; Porreca F Neuroreport; 1995 Nov; 6(17):2373-7. PubMed ID: 8747156 [TBL] [Abstract][Full Text] [Related]
16. Pharmacological profile of (R)-1-[2,3-dihydro-1-(2'-methylphenacyl)-2-oxo- 5-phenyl-1H-1,4-benzodiazepin-3-yl]-3-(3-methylphenyl)urea (YM022), a new potent and selective gastrin/cholecystokinin-B receptor antagonist, in vitro and in vivo. Nishida A; Miyata K; Tsutsumi R; Yuki H; Akuzawa S; Kobayashi A; Kamato T; Ito H; Yamano M; Katuyama Y J Pharmacol Exp Ther; 1994 May; 269(2):725-31. PubMed ID: 7910212 [TBL] [Abstract][Full Text] [Related]
17. Selective inhibition of pentagastrin- and cholecystokinin-stimulated exocrine secretion by proglumide. Loewe CJ; Grider JR; Gardiner J; Vlahcevic ZR Gastroenterology; 1985 Oct; 89(4):746-51. PubMed ID: 2863192 [TBL] [Abstract][Full Text] [Related]
18. Characterization of antisecretory and antiulcer activity of CR 2945, a new potent and selective gastrin/CCK(B) receptor antagonist. Makovec F; Revel L; Letari O; Mennuni L; Impicciatore M Eur J Pharmacol; 1999 Mar; 369(1):81-90. PubMed ID: 10204685 [TBL] [Abstract][Full Text] [Related]
19. Effects of cholecystokinin and gastrin antagonists on pancreatic exocrine secretion stimulated by gastrin-releasing peptide. Terashima H; Debas HT; Bunnett NW Pancreas; 1992; 7(2):212-9. PubMed ID: 1553370 [TBL] [Abstract][Full Text] [Related]
20. Characterization of CCK receptors in a novel smooth muscle preparation from the guinea-pig stomach by use of the selective antagonists CI-988, L-365,260 and devazepide. Boyle SJ; Tang KW; Woodruff GN; McKnight AT Br J Pharmacol; 1993 Aug; 109(4):913-7. PubMed ID: 8401944 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]